Printer Friendly

CEL-SCI CORPORATION ANNOUNCES PUBLIC OFFERING OF SECURITIES

 CEL-SCI CORPORATION ANNOUNCES PUBLIC OFFERING OF SECURITIES
 ALEXANDRIA, Va., Feb. 7 /PRNewswire/ -- CEL-SCI Corporation (NASDAQ: CELI) today announced the public offering of 900,000 units at a price of $15.50 per unit. Each unit consists of five shares of common stock and five warrants. Each warrant entitles the holder to purchase one share of common stock at a price of $4.65 per share through Feb. 6, 1995. The shares and warrants comprising the units are immediately separable and transferable. The company has also granted to the underwriter an option to sell and additional 135,000 units to cover over-allotments. The offering is being managed by Kober Financial Corp.
 CEL-SCI Corporation is a biotechnology company developing drugs for the treatment of cancer and the treatment/prevention of AIDS.
 A prospectus may be obtained from Corporation Finance Department, Kober Financial Corp., 8400 E. Prentice Ave., Suite 1100, Englewood, Colo., 80111.
 This announcement shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state.
 -0- 2/7/92
 /CONTACT: Matt Haines, 212-826-9622, or Daryll Strahl, 303-979-5735, both for CEL-SCI Corporation/
 (CELI) CO: CEL-SCI Corporation ST: Virginia IN: MTC SU: OFR


DC -- DC002 -- 8058 02/07/92 08:54 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 7, 1992
Words:236
Previous Article:HERCULES REPORTS FOURTH-QUARTER NET INCOME UP SUBSTANTIALLY FROM A YEAR AGO
Next Article:CERNER HOSPITAL-WIDE HNA SOLUTION FOR MANAGING CLINICAL INFORMATION TO BE IMPLEMENTED BY McLAREN REGIONAL MEDICAL CENTER
Topics:


Related Articles
CEL-SCI CORPORATION UNDERWRITERS EXERCISE OVER-ALLOTMENT OPTION
CEL-SCI CORPORATION LOWERS EXERCISE PRICE OF PUBLICLY HELD WARRANTS
CEL-SCI Repurchases $2.85 Million of Its Stock
CEL-SCI Corporation Announces Results of Annual Meeting and Plans to Shift to AMEX
CEL-SCI Corporation Common Stock and Warrants Trade on AMEX
CEL-SCI Corporation Announces Improvement In Terms of its Publicly Held Warrants
CEL-SCI Corporation Completes $10 Million Financing
CEL-SCI Corporation Extends Warrant Date
CEL-SCI Corporation Approved for Trading on Berlin Stock Exchange
CEL-SCI Aware of No Developments to Account for Recent Stock Activity

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters